Global Weight Loss Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 920880 | Published Date: Nov 2025 | No. of Page: 123 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Impact of U.S Tarrifs Analyzed 2025 

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Weight Loss Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Appetite Suppression
        1.2.3 Increasing Body Metabolism
        1.2.4 Interfering with the Digestion Absorption Patterns
    1.3 Market by Application
        1.3.1 Global Weight Loss Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Specialized Clinics
        1.3.4 Retail Pharmacies
        1.3.5 Mail Order Pharmacies
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Weight Loss Therapeutics Market Perspective (2016-2027)
    2.2 Weight Loss Therapeutics Growth Trends by Regions
        2.2.1 Weight Loss Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Weight Loss Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Weight Loss Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Weight Loss Therapeutics Industry Dynamic
        2.3.1 Weight Loss Therapeutics Market Trends
        2.3.2 Weight Loss Therapeutics Market Drivers
        2.3.3 Weight Loss Therapeutics Market Challenges
        2.3.4 Weight Loss Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Weight Loss Therapeutics Players by Revenue
        3.1.1 Global Top Weight Loss Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Weight Loss Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Weight Loss Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Weight Loss Therapeutics Revenue
    3.4 Global Weight Loss Therapeutics Market Concentration Ratio
        3.4.1 Global Weight Loss Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Weight Loss Therapeutics Revenue in 2020
    3.5 Weight Loss Therapeutics Key Players Head office and Area Served
    3.6 Key Players Weight Loss Therapeutics Product Solution and Service
    3.7 Date of Enter into Weight Loss Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Weight Loss Therapeutics Breakdown Data by Type
    4.1 Global Weight Loss Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Weight Loss Therapeutics Forecasted Market Size by Type (2022-2027)

5 Weight Loss Therapeutics Breakdown Data by Application
    5.1 Global Weight Loss Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Weight Loss Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Weight Loss Therapeutics Market Size (2016-2027)
    6.2 North America Weight Loss Therapeutics Market Size by Type
        6.2.1 North America Weight Loss Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Weight Loss Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Weight Loss Therapeutics Market Size by Type (2016-2027)
    6.3 North America Weight Loss Therapeutics Market Size by Application
        6.3.1 North America Weight Loss Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Weight Loss Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Weight Loss Therapeutics Market Size by Application (2016-2027)
    6.4 North America Weight Loss Therapeutics Market Size by Country
        6.4.1 North America Weight Loss Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Weight Loss Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Weight Loss Therapeutics Market Size (2016-2027)
    7.2 Europe Weight Loss Therapeutics Market Size by Type
        7.2.1 Europe Weight Loss Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Weight Loss Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Weight Loss Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Weight Loss Therapeutics Market Size by Application
        7.3.1 Europe Weight Loss Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Weight Loss Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Weight Loss Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Weight Loss Therapeutics Market Size by Country
        7.4.1 Europe Weight Loss Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Weight Loss Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Weight Loss Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Weight Loss Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Weight Loss Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Weight Loss Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Weight Loss Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Weight Loss Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Weight Loss Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Weight Loss Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Weight Loss Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Weight Loss Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Weight Loss Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Weight Loss Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Weight Loss Therapeutics Market Size (2016-2027)
    9.2 Latin America Weight Loss Therapeutics Market Size by Type
        9.2.1 Latin America Weight Loss Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Weight Loss Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Weight Loss Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Weight Loss Therapeutics Market Size by Application
        9.3.1 Latin America Weight Loss Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Weight Loss Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Weight Loss Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Weight Loss Therapeutics Market Size by Country
        9.4.1 Latin America Weight Loss Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Weight Loss Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Weight Loss Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Weight Loss Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Weight Loss Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Weight Loss Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Weight Loss Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Weight Loss Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Weight Loss Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Weight Loss Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Weight Loss Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Weight Loss Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Weight Loss Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott
        11.1.1 Abbott Company Details
        11.1.2 Abbott Business Overview
        11.1.3 Abbott Weight Loss Therapeutics Introduction
        11.1.4 Abbott Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.1.5 Abbott Recent Development
    11.2 Sanofi
        11.2.1 Sanofi Company Details
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Weight Loss Therapeutics Introduction
        11.2.4 Sanofi Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.2.5 Sanofi Recent Development
    11.3 Novo Nordisk
        11.3.1 Novo Nordisk Company Details
        11.3.2 Novo Nordisk Business Overview
        11.3.3 Novo Nordisk Weight Loss Therapeutics Introduction
        11.3.4 Novo Nordisk Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.3.5 Novo Nordisk Recent Development
    11.4 Arena Pharmaceuticals
        11.4.1 Arena Pharmaceuticals Company Details
        11.4.2 Arena Pharmaceuticals Business Overview
        11.4.3 Arena Pharmaceuticals Weight Loss Therapeutics Introduction
        11.4.4 Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.4.5 Arena Pharmaceuticals Recent Development
    11.5 Orexigen Therapeutics
        11.5.1 Orexigen Therapeutics Company Details
        11.5.2 Orexigen Therapeutics Business Overview
        11.5.3 Orexigen Therapeutics Weight Loss Therapeutics Introduction
        11.5.4 Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.5.5 Orexigen Therapeutics Recent Development
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Company Details
        11.6.2 Johnson & Johnson Business Overview
        11.6.3 Johnson & Johnson Weight Loss Therapeutics Introduction
        11.6.4 Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.6.5 Johnson & Johnson Recent Development
    11.7 Pfizer
        11.7.1 Pfizer Company Details
        11.7.2 Pfizer Business Overview
        11.7.3 Pfizer Weight Loss Therapeutics Introduction
        11.7.4 Pfizer Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.7.5 Pfizer Recent Development
    11.8 Novartis AG
        11.8.1 Novartis AG Company Details
        11.8.2 Novartis AG Business Overview
        11.8.3 Novartis AG Weight Loss Therapeutics Introduction
        11.8.4 Novartis AG Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.8.5 Novartis AG Recent Development
    11.9 Biocon
        11.9.1 Biocon Company Details
        11.9.2 Biocon Business Overview
        11.9.3 Biocon Weight Loss Therapeutics Introduction
        11.9.4 Biocon Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.9.5 Biocon Recent Development
    11.10 VIVUS
        11.10.1 VIVUS Company Details
        11.10.2 VIVUS Business Overview
        11.10.3 VIVUS Weight Loss Therapeutics Introduction
        11.10.4 VIVUS Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.10.5 VIVUS Recent Development
    11.11 Eli Lilly
        11.11.1 Eli Lilly Company Details
        11.11.2 Eli Lilly Business Overview
        11.11.3 Eli Lilly Weight Loss Therapeutics Introduction
        11.11.4 Eli Lilly Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.11.5 Eli Lilly Recent Development
    11.12 Amgen
        11.12.1 Amgen Company Details
        11.12.2 Amgen Business Overview
        11.12.3 Amgen Weight Loss Therapeutics Introduction
        11.12.4 Amgen Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.12.5 Amgen Recent Development
    11.13 Zafgen
        11.13.1 Zafgen Company Details
        11.13.2 Zafgen Business Overview
        11.13.3 Zafgen Weight Loss Therapeutics Introduction
        11.13.4 Zafgen Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.13.5 Zafgen Recent Development
    11.14 Roche
        11.14.1 Roche Company Details
        11.14.2 Roche Business Overview
        11.14.3 Roche Weight Loss Therapeutics Introduction
        11.14.4 Roche Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.14.5 Roche Recent Development
    11.15 Eisai
        11.15.1 Eisai Company Details
        11.15.2 Eisai Business Overview
        11.15.3 Eisai Weight Loss Therapeutics Introduction
        11.15.4 Eisai Revenue in Weight Loss Therapeutics Business (2016-2021)
        11.15.5 Eisai Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Weight Loss Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Appetite Suppression
    Table 3. Key Players of Increasing Body Metabolism
    Table 4. Key Players of Interfering with the Digestion Absorption Patterns
    Table 5. Global Weight Loss Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Weight Loss Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Weight Loss Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Weight Loss Therapeutics Market Share by Regions (2016-2021)
    Table 9. Global Weight Loss Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Weight Loss Therapeutics Market Share by Regions (2022-2027)
    Table 11. Weight Loss Therapeutics Market Trends
    Table 12. Weight Loss Therapeutics Market Drivers
    Table 13. Weight Loss Therapeutics Market Challenges
    Table 14. Weight Loss Therapeutics Market Restraints
    Table 15. Global Weight Loss Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Weight Loss Therapeutics Market Share by Players (2016-2021)
    Table 17. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Therapeutics as of 2020)
    Table 18. Ranking of Global Top Weight Loss Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Weight Loss Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Weight Loss Therapeutics Product Solution and Service
    Table 22. Date of Enter into Weight Loss Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Weight Loss Therapeutics Revenue Market Share by Type (2016-2021)
    Table 26. Global Weight Loss Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Weight Loss Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Weight Loss Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Weight Loss Therapeutics Revenue Market Share by Application (2016-2021)
    Table 30. Global Weight Loss Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Weight Loss Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Weight Loss Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Weight Loss Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Weight Loss Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Weight Loss Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Weight Loss Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Weight Loss Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Weight Loss Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Weight Loss Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Weight Loss Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Weight Loss Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Weight Loss Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Weight Loss Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Weight Loss Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Weight Loss Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Abbott Company Details
    Table 63. Abbott Business Overview
    Table 64. Abbott Weight Loss Therapeutics Product
    Table 65. Abbott Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 66. Abbott Recent Development
    Table 67. Sanofi Company Details
    Table 68. Sanofi Business Overview
    Table 69. Sanofi Weight Loss Therapeutics Product
    Table 70. Sanofi Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 71. Sanofi Recent Development
    Table 72. Novo Nordisk Company Details
    Table 73. Novo Nordisk Business Overview
    Table 74. Novo Nordisk Weight Loss Therapeutics Product
    Table 75. Novo Nordisk Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 76. Novo Nordisk Recent Development
    Table 77. Arena Pharmaceuticals Company Details
    Table 78. Arena Pharmaceuticals Business Overview
    Table 79. Arena Pharmaceuticals Weight Loss Therapeutics Product
    Table 80. Arena Pharmaceuticals Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 81. Arena Pharmaceuticals Recent Development
    Table 82. Orexigen Therapeutics Company Details
    Table 83. Orexigen Therapeutics Business Overview
    Table 84. Orexigen Therapeutics Weight Loss Therapeutics Product
    Table 85. Orexigen Therapeutics Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 86. Orexigen Therapeutics Recent Development
    Table 87. Johnson & Johnson Company Details
    Table 88. Johnson & Johnson Business Overview
    Table 89. Johnson & Johnson Weight Loss Therapeutics Product
    Table 90. Johnson & Johnson Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 91. Johnson & Johnson Recent Development
    Table 92. Pfizer Company Details
    Table 93. Pfizer Business Overview
    Table 94. Pfizer Weight Loss Therapeutics Product
    Table 95. Pfizer Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 96. Pfizer Recent Development
    Table 97. Novartis AG Company Details
    Table 98. Novartis AG Business Overview
    Table 99. Novartis AG Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 100. Novartis AG Recent Development
    Table 101. Biocon Company Details
    Table 102. Biocon Business Overview
    Table 103. Biocon Weight Loss Therapeutics Product
    Table 104. Biocon Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 105. Biocon Recent Development
    Table 106. VIVUS Company Details
    Table 107. VIVUS Business Overview
    Table 108. VIVUS Weight Loss Therapeutics Product
    Table 109. VIVUS Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 110. VIVUS Recent Development
    Table 111. Eli Lilly Company Details
    Table 112. Eli Lilly Business Overview
    Table 113. Eli Lilly Weight Loss Therapeutics Product
    Table 114. Eli Lilly Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 115. Eli Lilly Recent Development
    Table 116. Amgen Company Details
    Table 117. Amgen Business Overview
    Table 118. Amgen Weight Loss Therapeutics Product
    Table 119. Amgen Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 120. Amgen Recent Development
    Table 121. Zafgen Company Details
    Table 122. Zafgen Business Overview
    Table 123. Zafgen Weight Loss Therapeutics Product
    Table 124. Zafgen Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 125. Zafgen Recent Development
    Table 126. Roche Company Details
    Table 127. Roche Business Overview
    Table 128. Roche Weight Loss Therapeutics Product
    Table 129. Roche Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 130. Roche Recent Development
    Table 131. Eisai Company Details
    Table 132. Eisai Business Overview
    Table 133. Eisai Weight Loss Therapeutics Product
    Table 134. Eisai Revenue in Weight Loss Therapeutics Business (2016-2021) & (US$ Million)
    Table 135. Eisai Recent Development
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Weight Loss Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. Appetite Suppression Features
    Figure 3. Increasing Body Metabolism Features
    Figure 4. Interfering with the Digestion Absorption Patterns Features
    Figure 5. Global Weight Loss Therapeutics Market Share by Application: 2020 VS 2027
    Figure 6. Hospitals Case Studies
    Figure 7. Specialized Clinics Case Studies
    Figure 8. Retail Pharmacies Case Studies
    Figure 9. Mail Order Pharmacies Case Studies
    Figure 10. Others Case Studies
    Figure 11. Weight Loss Therapeutics Report Years Considered
    Figure 12. Global Weight Loss Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Weight Loss Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Weight Loss Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 15. Global Weight Loss Therapeutics Market Share by Regions (2022-2027)
    Figure 16. Global Weight Loss Therapeutics Market Share by Players in 2020
    Figure 17. Global Top Weight Loss Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Weight Loss Therapeutics as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Weight Loss Therapeutics Revenue in 2020
    Figure 19. Global Weight Loss Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 20. Global Weight Loss Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 21. North America Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Weight Loss Therapeutics Market Share by Type (2016-2027)
    Figure 23. North America Weight Loss Therapeutics Market Share by Application (2016-2027)
    Figure 24. North America Weight Loss Therapeutics Market Share by Country (2016-2027)
    Figure 25. United States Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Weight Loss Therapeutics Market Share by Type (2016-2027)
    Figure 29. Europe Weight Loss Therapeutics Market Share by Application (2016-2027)
    Figure 30. Europe Weight Loss Therapeutics Market Share by Country (2016-2027)
    Figure 31. Germany Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Weight Loss Therapeutics Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Weight Loss Therapeutics Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Weight Loss Therapeutics Market Share by Region (2016-2027)
    Figure 41. China Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Weight Loss Therapeutics Market Share by Type (2016-2027)
    Figure 49. Latin America Weight Loss Therapeutics Market Share by Application (2016-2027)
    Figure 50. Latin America Weight Loss Therapeutics Market Share by Country (2016-2027)
    Figure 51. Mexico Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Weight Loss Therapeutics Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Weight Loss Therapeutics Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Weight Loss Therapeutics Market Share by Country (2016-2027)
    Figure 57. Turkey Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Weight Loss Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Abbott Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 61. Sanofi Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 62. Novo Nordisk Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 63. Arena Pharmaceuticals Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 64. Orexigen Therapeutics Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 65. Johnson & Johnson Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 66. Pfizer Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 67. Novartis AG Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 68. Biocon Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 69. VIVUS Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 70. Eli Lilly Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 71. Amgen Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 72. Zafgen Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 73. Roche Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 74. Eisai Revenue Growth Rate in Weight Loss Therapeutics Business (2016-2021)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Sanofi
Novo Nordisk
Arena Pharmaceuticals
Orexigen Therapeutics
Johnson & Johnson
Pfizer
Novartis AG
Biocon
VIVUS
Eli Lilly
Amgen
Zafgen
Roche
Eisai
Frequently Asked Questions
Weight Loss Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Weight Loss Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Weight Loss Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports